Metraipolis › archive › dc_7ddf50006637

Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma — Europe PMC PMID:42774230

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42774230
DOI
10.3389/fimmu.2026.1919613
License (as archived)
solo-consultazione
Archived
2026-10-16T00:38:00.552Z
SHA-256 of the archived text
c39d4ebe4bec289b6c81f0520c8847d829bf5e064a028529fe0aea4559e34373
Stable URL of this page
https://metraipolis.com/documento/dc_7ddf50006637

How to cite

Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma — Europe PMC PMID:42774230 — Europe PMC (en), https://europepmc.org/article/MED/42774230 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ddf50006637 (Metraipolis archive dc_7ddf50006637, sha256 c39d4ebe4bec289b6c81f0520c8847d829bf5e064a028529fe0aea4559e34373)
BibTeX
@misc{dc7ddf50006637,
  title = {Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma — Europe PMC PMID:42774230},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42774230},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ddf50006637; sha256 c39d4ebe4bec289b6c81f0520c8847d829bf5e064a028529fe0aea4559e34373},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774230. Agents can read the archived copy with the MCP tool read_document.